1 September 2022
Board Committee Membership
Smith & Nephew plc (LSE:SN, NYSE:SNN) announces that the Board has resolved to appoint Jo Hallas, Independent Non-Executive Director, as a member of the Audit Committee and Angie Risley, Independent Non-Executive Director, as a member of the Nomination & Governance Committee. Both appointments are effective 1 September 2022.
This announcement has been made in accordance with the requirements of 9.6.11(3) of the Listing Rules.
Enquiries
|
Investors |
|
|
Andrew Swift |
+44 (0) 1923 477433 |
|
Smith+Nephew |
|
|
Media |
|
|
Charles Reynolds |
+44 (0) 1923 477314 |
|
Smith+Nephew |
|
|
Susan Gilchrist / Ayesha Bharmal |
+44 (0) 20 7404 5959 |
|
Brunswick |
About Smith+Nephew
Smith+Nephew is a portfolio medical technology company that exists to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 18,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.2 billion in 2021. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.
For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on Twitter , LinkedIn , Instagram or Facebook .